Marshall Fordyce is PRESIDENT AND CEO of Vera Therapeutics, Inc.. Currently has a direct ownership of 335,627 shares of VERA, which is worth approximately $12.8 Million. The most recent transaction as insider was on Jan 16, 2024, when has been sold 78,750 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 336K
0% 3M change
36.27% 12M change
Total Value Held $12.8 Million

Marshall Fordyce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2024
BUY
Grant, award, or other acquisition
-
78,750 Added 19.0%
335,627 Class A Common Stock
Dec 29 2023
BUY
Exercise of conversion of derivative security
$35,276 $2.61 p/Share
13,516 Added 5.0%
256,877 Class A Common Stock
Aug 21 2023
SELL
Open market or private sale
$86,798 $16.66 p/Share
5,210 Reduced 2.1%
243,361 Class A Common Stock
Nov 16 2022
BUY
Exercise of conversion of derivative security
$170,049 $2.61 p/Share
65,153 Added 20.92%
246,303 Class A Common Stock
Oct 04 2022
SELL
Open market or private sale
$389,790 $21.39 p/Share
18,223 Reduced 9.14%
181,150 Class A Common Stock
Oct 04 2022
BUY
Exercise of conversion of derivative security
$52,847 $2.9 p/Share
18,223 Added 9.1%
182,056 Class A Common Stock
Oct 03 2022
SELL
Open market or private sale
$286,286 $20.78 p/Share
13,777 Reduced 7.07%
181,150 Class A Common Stock
Oct 03 2022
BUY
Exercise of conversion of derivative security
$39,953 $2.9 p/Share
13,777 Added 6.98%
183,558 Class A Common Stock
Sep 13 2022
SELL
Open market or private sale
$472,530 $21.13 p/Share
22,363 Reduced 10.99%
181,150 Class A Common Stock
Sep 13 2022
BUY
Exercise of conversion of derivative security
$64,853 $2.9 p/Share
22,363 Added 10.37%
193,350 Class A Common Stock
Sep 12 2022
SELL
Open market or private sale
$335,629 $20.8 p/Share
16,136 Reduced 8.18%
181,150 Class A Common Stock
Sep 12 2022
BUY
Exercise of conversion of derivative security
$46,794 $2.9 p/Share
16,136 Added 8.04%
184,465 Class A Common Stock
Sep 09 2022
SELL
Open market or private sale
$259,782 $20.16 p/Share
12,886 Reduced 6.64%
181,150 Class A Common Stock
Sep 09 2022
BUY
Exercise of conversion of derivative security
$37,369 $2.9 p/Share
12,886 Added 6.23%
194,036 Class A Common Stock
Sep 08 2022
SELL
Open market or private sale
$309,975 $20.52 p/Share
15,106 Reduced 7.7%
181,150 Class A Common Stock
Sep 08 2022
BUY
Exercise of conversion of derivative security
$43,807 $2.9 p/Share
15,106 Added 7.15%
196,256 Class A Common Stock
Sep 07 2022
SELL
Open market or private sale
$135,904 $20.03 p/Share
6,785 Reduced 3.61%
181,150 Class A Common Stock
Sep 07 2022
BUY
Exercise of conversion of derivative security
$19,677 $2.9 p/Share
6,785 Added 3.48%
187,935 Class A Common Stock
Sep 02 2022
SELL
Open market or private sale
$356,964 $20.88 p/Share
17,096 Reduced 8.62%
181,150 Class A Common Stock
Sep 02 2022
BUY
Exercise of conversion of derivative security
$49,578 $2.9 p/Share
17,096 Added 8.22%
190,900 Class A Common Stock
Sep 01 2022
SELL
Open market or private sale
$362,862 $21.22 p/Share
17,100 Reduced 8.63%
181,150 Class A Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
$49,590 $2.9 p/Share
17,100 Added 7.94%
198,250 Class A Common Stock
Aug 19 2022
BUY
Grant, award, or other acquisition
-
43,750 Added 19.45%
181,150 Class A Common Stock
Aug 12 2022
SELL
Open market or private sale
$413,844 $20.16 p/Share
20,528 Reduced 13.0%
137,400 Class A Common Stock
Aug 12 2022
BUY
Exercise of conversion of derivative security
$59,531 $2.9 p/Share
20,528 Added 11.5%
157,928 Class A Common Stock
MF

Marshall Fordyce

PRESIDENT AND CEO
Brisbane, CA

Track Institutional and Insider Activities on VERA

Follow Vera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERA shares.

Notify only if

Insider Trading

Get notified when an Vera Therapeutics, Inc. insider buys or sells VERA shares.

Notify only if

News

Receive news related to Vera Therapeutics, Inc.

Track Activities on VERA